 Fibrin fragment D-dimer fibrinogen beta peptides plasma markers clot lysis thrombolytic therapy acute myocardial infarction validity markers plasma vitro thrombolysis patients extensive fibrinogen breakdown group patients minimal breakdown group patients mg recombinant tissue-type plasminogen activator rt-PA Thrombolysis Myocardial Infarction II TIMI II trial Cross-linked fibrin degradation product levels variant enzyme-linked immunosorbent assays ELISAs fibrin fragment D-dimer specific capture antibody instance tag antibody cross-reacts fibrinogen pan-specific tag ELISA tag antibody specific fibrin fragment fibrin-specific tag ELISA Apparent concentrations cross-linked fibrin degradation products baseline normal limits assays patients hours rt-PA infusion cross-linked fibrin degradation products twofold group assays group levels pan-specific tag ELISA micrograms/mL fibrin-specific tag ELISA micrograms/mL observation result detection fibrinogen degradation products pan-specific ELISA Apparent levels fibrinopeptide beta marker fragment formation thrombolysis pmol/mL pmol/mL group pmol/mL pmol/mL group extent fibrinogen breakdown Fibrinopeptide levels pmol/mL pmol/mL group group apparent increase group cross-reactivity fibrinopeptide beta fibrinopeptide beta assay cross-linked fibrin degradation product levels pan-specific tag ELISA fibrinopeptide beta levels certain monoclonal antibody-based ELISA extent fibrinogen degradation Fibrinopeptide beta marker specific fibrinogen breakdown Cross-linked fibrin degradation product levels fibrin-specific tag ELISA markers specific thrombolysis similar fibrin-specific tag ELISA accurate information clinical endpoints